Patient experiences using Evra [Estradiol/progestogen] for management of menstrual related symptoms
Latest Information Update: 31 Aug 2013
Price :
$35 *
At a glance
- Drugs Ethinylestradiol/norelgestromin (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- 28 Aug 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 02 Nov 2006 New trial record.